SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE H impact

DELAYED UPDATE — Pfizer raises 2026 outlook; agrees Minipress IP sale in India

Pfizer reported Q2 revenue of $15.03B and $0.77 adjusted EPS. It raised its 2026 revenue outlook and agreed to sell Minipress/Minipres IP in India to Novartis India for ₹1,250 crore.

PFE

Pfizer Inc. (NYSE:PFE) posted Q2 revenue of $15.03B and $0.77 adj. EPS, raised its 2026 revenue outlook as FDA cleared an updated 2026—27 COVID vaccine and Phase 3 Lyme results impressed, while it agreed to sell Minipress/Minipres IP in India to Novartis India for ₹1,250 crore.Previous Week RecapTh…

Related stories